Healthcare provider profile · identity verified

Travis W Lockwood, MD

Family Practice · COTTAGE GROVE, MN · NPI 1396708921

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	395	106
Metoprolol Succinate	Metoprolol Succinate	249	69
Simvastatin	Simvastatin	222	57
Lisinopril	Lisinopril	216	58
Omeprazole	Omeprazole	196	66
Losartan Potassium	Losartan Potassium	194	53
Levothyroxine Sodium	Levothyroxine Sodium	181	45
Metformin Hcl Er	Metformin Hcl	167	49
Rosuvastatin Calcium	Rosuvastatin Calcium	164	56
Tamsulosin Hcl	Tamsulosin Hcl	162	42
Amlodipine Besylate	Amlodipine Besylate	157	46
Allopurinol	Allopurinol	156	41
Gabapentin	Gabapentin	155	50
Furosemide	Furosemide	129	40
Chlorthalidone	Chlorthalidone	118	32
Trazodone Hcl	Trazodone Hcl	110	39
Metformin Hcl	Metformin Hcl	109	31
Hydrochlorothiazide	Hydrochlorothiazide	93	28
Metoprolol Tartrate	Metoprolol Tartrate	91	23
Telmisartan	Telmisartan	90	24
Mounjaro	Tirzepatide	79	15
Glipizide Er	Glipizide	78	24
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	78	13
Potassium Chloride	Potassium Chloride	78	17
Xarelto	Rivaroxaban	74	22
Prednisone	Prednisone	68	48
Tizanidine Hcl	Tizanidine Hcl	68	39
Eliquis	Apixaban	65	12
Atenolol	Atenolol	61	15
Albuterol Sulfate Hfa	Albuterol Sulfate	60	28
Famotidine	Famotidine	57	17
Mirtazapine	Mirtazapine	56	14
Clopidogrel	Clopidogrel Bisulfate	55	15
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	53	15
Duloxetine Hcl	Duloxetine Hcl	51	16
Pantoprazole Sodium	Pantoprazole Sodium	51	15
Zolpidem Tartrate	Zolpidem Tartrate	51	suppressed
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	50	30
Carvedilol	Carvedilol	49	12
Sertraline Hcl	Sertraline Hcl	49	15
Tramadol Hcl	Tramadol Hcl	47	11
Warfarin Sodium	Warfarin Sodium	47	17
Finasteride	Finasteride	45	12
Pregabalin	Pregabalin	43	16
Valsartan	Valsartan	43	suppressed
Montelukast Sodium	Montelukast Sodium	42	suppressed
Celecoxib	Celecoxib	41	13
Fluticasone Propionate	Fluticasone Propionate	41	17
Triamcinolone Acetonide	Triamcinolone Acetonide	41	16
Buspirone Hcl	Buspirone Hcl	39	15
Fluoxetine Hcl	Fluoxetine Hcl	38	11
Trulicity	Dulaglutide	38	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	37	suppressed
Meloxicam	Meloxicam	37	18
Dextroamphetamine-Amphet Er	Dextroamphetamine/Amphetamine	36	suppressed
Pravastatin Sodium	Pravastatin Sodium	35	suppressed
Glipizide	Glipizide	33	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	33	suppressed
Fluconazole	Fluconazole	31	17
Donepezil Hcl	Donepezil Hcl	30	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	30	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	30	suppressed
Azithromycin	Azithromycin	29	20
Ezetimibe	Ezetimibe	29	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	29	suppressed
Paroxetine Hcl	Paroxetine Hcl	29	suppressed
Cephalexin	Cephalexin	28	21
Clonidine	Clonidine	28	suppressed
Citalopram Hbr	Citalopram Hydrobromide	27	suppressed
Ozempic	Semaglutide	26	suppressed
Lorazepam	Lorazepam	25	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	25	suppressed
Verapamil Sr	Verapamil Hcl	25	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	24	suppressed
Bupropion Xl	Bupropion Hcl	23	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	23	11
Amoxicillin	Amoxicillin	22	12
Lovastatin	Lovastatin	21	suppressed
Mupirocin	Mupirocin	21	18
Doxazosin Mesylate	Doxazosin Mesylate	20	suppressed
Irbesartan	Irbesartan	20	suppressed
Memantine Hcl	Memantine Hcl	20	suppressed
Rybelsus	Semaglutide	20	suppressed
Terazosin Hcl	Terazosin Hcl	20	suppressed
Clonidine Hcl	Clonidine Hcl	19	suppressed
Verapamil Er	Verapamil Hcl	19	suppressed
Diclofenac Sodium	Diclofenac Sodium	18	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	18	suppressed
Ondansetron Odt	Ondansetron	18	suppressed
Bumetanide	Bumetanide	17	suppressed
Klor-Con M20	Potassium Chloride	17	suppressed
Nystatin	Nystatin	17	suppressed
Ventolin Hfa	Albuterol Sulfate	16	suppressed
Estradiol	Estradiol	15	suppressed
Eszopiclone	Eszopiclone	15	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	15	suppressed
Glimepiride	Glimepiride	15	suppressed
Levofloxacin	Levofloxacin	15	12
Myrbetriq	Mirabegron	15	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	15	15
Spironolactone	Spironolactone	15	suppressed
Nitroglycerin	Nitroglycerin	14	11
Oxybutynin Chloride	Oxybutynin Chloride	14	suppressed
Oxycodone Hcl	Oxycodone Hcl	14	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	14	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	14	suppressed
Autoshield Duo Pen Needle	Pen Needle,dual Safety,diabetc	13	suppressed
Bupropion Hcl Sr	Bupropion Hcl	13	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	13	12
Levetiracetam	Levetiracetam	13	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	13	suppressed
Cefuroxime	Cefuroxime Axetil	12	suppressed
Humalog Kwikpen U-100	Insulin Lispro	12	suppressed
Lidocaine	Lidocaine	12	suppressed
Metronidazole	Metronidazole	12	suppressed
Novolog Flexpen	Insulin Aspart	12	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	12	suppressed
Ramipril	Ramipril	12	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	12	suppressed
Azelastine Hcl	Azelastine Hcl	11	suppressed
Butalbital-Acetaminophen-Caffe	Butalb/Acetaminophen/Caffeine	11	suppressed
Fenofibrate	Fenofibrate	11	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	11	suppressed
Morphine Sulfate Er	Morphine Sulfate	11	suppressed
Niacin Er	Niacin	11	suppressed
Nifedipine Er	Nifedipine	11	suppressed
Otrexup	Methotrexate/Pf	11	suppressed
Primidone	Primidone	11	suppressed
Rizatriptan	Rizatriptan Benzoate	11	suppressed
Tadalafil	Tadalafil	11	suppressed
Ultra-Fine Mini Pen Needle	Pen Needle, Diabetic	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error